Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

36 Press Releases
DateTitleCompany
16 Nov 15 GSK, COPD Foundation and AARC Team Up for #COPDChat, November 9th, 12 pm ET GSK,
Published by
PharmiWeb.com
24 Jul 15 GSK’s Malaria Vaccine Containing Agenus’ QS-21 Stimulon® Receives Positive Opinion from European Regulators for Prevention of Malaria in Young Children in Sub-Saharan Africa GSK,
Published by
PharmiWeb.com
30 Jun 15 TUMS® Celebrates American Barbecue GSK,
Published by
PR Newswire
24 Mar 15 GSK’s 2015 Discovery Fast Track Challenge seeks early drug discovery partnerships with academics in Europe, Canada and US GSK,
Published by
PharmiWeb.com
01 Dec 14 GSK Names Winners of 2014 Discovery Fast Track Challenge GSK,
Published by
Business Wire
01 Apr 14 Results from phase III patient preference study of GSK’s Votrient® (pazopanib) vs. Sutent® (sunitinib) in advanced renal cell carcinoma published in Journal of Clinical Oncology GSK,
Published by
Pharmiweb
25 Feb 14 GSK kicks off 2014 Discovery Fast Track Challenge for academic drug hunters in Europe, Canada and US GSK,
Published by
Business Wire
03 Feb 14 Tafinlar® approved for use in England through the CDF for the treatment of metastatic melanoma patients GSK,
Published by
Packer Forbes
06 Nov 13 GSK Names Inaugural Winners in Unique Competition for Academic Drug Hunters GSK,
Published by
Business Wire
09 May 13 GSK and Save the Children form unique partnership to save the lives of one million children GSK,
Published by
PharmiWeb.com
26 Nov 12 GSK initiates voluntary open offer to increase stake in its publically-listed Consumer Healthcare subsidiary in India GSK,
Published by
Pharmiweb.com
01 Oct 12 Head-to-head study of GSK’s Votrient®(pazopanib) vs sunitinib in advanced renal cell carcinoma meets primary endpoint; findings presented at ESMO 2012 Congress GSK,
Published by
Packer Forbes
26 May 11 Clinical trial of malaria vaccine begins in Africa GSK,
Published by
PharmiWeb.com
07 Mar 11 Advanced kidney cancer patients now able to access Votrient®? (pazopanib) on NHS Scotland GSK
02 Mar 11 GSK outlines new plan to drive recruitment and attract graduate talent in the UK GSK
23 Feb 11 New treatment choice for advanced kidney cancer patients as Votrient®? (pazopanib) made available on the NHS GSK
06 Sep 10 GlaxoSmithKline pre-broadcast statement: BBC Panorama, 6 September 2010 GSK,
Published by
PharmiWeb.com
06 Sep 10 GlaxoSmithKline responds to British Medical Journal article regarding Avandia® (rosiglitazone) GSK,
Published by
PharmiWeb.com
17 Aug 09 GSK - Pandemic (H1N1) 2009 influenza update GSK,
Published by
PharmiWeb.com
18 Aug 09 GSK and Brazil’s Fiocruz form partnership for new R&D effort and increased vaccine access GSK,
Published by
PharmiWeb.com
03 Jul 09 GSK further extends its product portfolio in the Middle East and North Africa GSK,
Published by
PharmiWeb.com
08 Jun 09 Study shows GSK’s novel diabetes treatment Syncria® (albiglutide) improves glucose control and reduces weight GSK,
Published by
PharmiWeb.com
21 Apr 09 GlaxoSmithKline launches alli® (orlistat 60 mg) GSK,
Published by
PharmiWeb
09 Mar 09 NICE Refuses Funding For Advanced Breast Cancer GSK,
Published by
Packer Forbes Communications
12 Oct 09 Avodart® (dutasteride) in combination with tamsulosin shows benefits for men with benign prostatic hyperplasia (enlarged prostate) GSK,
Published by
PharmiWeb.com
18 May 09 GlaxoSmithKline update: A (H1N1) influenza vaccine development GSK
02 Jun 09 GSK's Pazopanib significantly delayed tumor progression in patients with advanced kidney cancer GSK,
Published by
PharmiWeb.com
20 Apr 10 Arzerra® ? (ofatumumab) receives conditional European marketing authorisation for refractory chronic lymphocytic leukaemia (CLL) GSK
15 Mar 10 Revolade®? (eltrombopag) receives European marketing authorisation for the treatment of chronic immune thrombocytopenic purpura (ITP) GSK,
Published by
PharmiWeb.com
14 Dec 09 GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer GSK,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.